The Cooper Companies, Inc. (NASDAQ:COO) Receives Average Rating of “Hold” from Brokerages

Shares of The Cooper Companies, Inc. (NASDAQ:COO) have earned an average rating of “Hold” from the seventeen ratings firms that are currently covering the firm, MarketBeat.com reports. Three research analysts have rated the stock with a sell rating, six have issued a hold rating, seven have given a buy rating and one has given a strong buy rating to the company. The average 12-month price objective among analysts that have covered the stock in the last year is $81.6429.

Several research firms have recently weighed in on COO. Mizuho set a $85.00 target price on Cooper Companies and gave the company an “outperform” rating in a research report on Thursday, June 4th. KeyCorp reiterated a “sector weight” rating on shares of Cooper Companies in a research report on Friday, June 5th. JPMorgan Chase & Co. reduced their price objective on Cooper Companies from $80.00 to $71.00 and set a “neutral” rating for the company in a research note on Friday, June 5th. Weiss Ratings lowered Cooper Companies from a “hold (c-)” rating to a “sell (d)” rating in a report on Monday, June 8th. Finally, Wall Street Zen raised shares of Cooper Companies from a “hold” rating to a “buy” rating in a research note on Sunday, June 21st.

Hedge Funds Weigh In On Cooper Companies

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Avalon Trust Co acquired a new stake in Cooper Companies in the 2nd quarter valued at about $25,000. Root Financial Partners LLC boosted its holdings in shares of Cooper Companies by 104.5% during the 4th quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock worth $26,000 after purchasing an additional 162 shares during the last quarter. SJS Investment Consulting Inc. grew its position in shares of Cooper Companies by 107.5% in the first quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company’s stock valued at $26,000 after purchasing an additional 187 shares in the last quarter. Elevation Wealth Partners LLC grew its position in shares of Cooper Companies by 1,136.4% in the second quarter. Elevation Wealth Partners LLC now owns 408 shares of the medical device company’s stock valued at $29,000 after purchasing an additional 375 shares in the last quarter. Finally, J.Safra Asset Management Corp acquired a new stake in shares of Cooper Companies in the second quarter valued at approximately $32,000. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Cooper Companies Stock Down 0.2%

Shares of NASDAQ COO opened at $76.60 on Friday. The firm has a market cap of $14.94 billion, a price-to-earnings ratio of 64.92, a price-to-earnings-growth ratio of 2.01 and a beta of 0.83. The company’s 50-day simple moving average is $70.92 and its 200-day simple moving average is $71.29. The company has a quick ratio of 0.78, a current ratio of 1.27 and a debt-to-equity ratio of 0.23. Cooper Companies has a 52-week low of $58.89 and a 52-week high of $89.83.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, topping the consensus estimate of $1.10 by $0.11. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The firm had revenue of $1.08 billion during the quarter, compared to the consensus estimate of $1.05 billion. During the same quarter in the prior year, the firm earned $0.96 EPS. The company’s revenue for the quarter was up 7.9% on a year-over-year basis. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Equities analysts predict that Cooper Companies will post 4.63 EPS for the current fiscal year.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.